SAB Biotherapeutics, Inc. (SABSW) Stock Price & Growth Analysis

Quote Panel

Updated October 29, 2024

1W -7.90 % 1M 39.17 % 3M 0.20 % 1Y -45.08 %

Key Metrics

Market Cap
25.57M
Shares Outstanding
510.28M
Share in Float
Dividende
0

Earning Date
No Data
Price Target
0.0501
Average Volume
Beta
0.698

Range
0.05-0.0515
Industry
Biotechnology
Website
http://www.sabbiotherapeutics.com
Sector
Healthcare

Fundamentals

N/A

P/E Ratio

9.69x

P/S Ratio

0.59x

P/B Ratio

0.1

Debt/Equity

-1450.3%

Net Margin

$0.3

EPS

How SABSW compares to sector?

P/E Ratio

Relative Strength

SABSW

Sector

Top 5 RS in Group

Symbol	Company	RS	5-Day Perf.

Forecast

No Data Available

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings Growth

YoY

Current

Estimates

Q1.22

N/A

NA
vs NA

Q2.22

N/A

NA
vs NA

Q3.22

N/A

NA
vs NA

Q4.22

N/A

-0.18
vs NA

Q1.23

N/A

-0.15
vs NA

Q2.23

N/A

-0.14
vs NA

Q3.23

N/A

-0.10
vs NA

Q4.23

N/A

NA
vs -0.18

Q1.24

N/A

NA
vs -0.15

Q2.24

N/A

NA
vs -0.14

Sales Growth

YoY

Current

Estimates

Q1.22

11.8M vs NA

Q2.22

6.4M vs NA

Q3.22

3.6M vs NA

Q4.22

-96%

2.2M vs 60.9M

Q1.23

-95%

581.1K vs 11.8M

Q2.23

-99%

85.5K vs 6.4M

Q3.23

-65%

1.3M vs 3.6M

Q4.23

-86%

305K vs 2.2M

Q1.24

+63%

944.6K vs 581.1K

Q2.24

+208%

263.1K vs 85.5K

Return on Equity

QoQ

Q3.22

-21%

-0.21
vs -0.13

Q4.22

-25%

-0.25
vs -0.21

Q1.23

-30%

-0.30
vs -0.25

Q2.23

-35%

-0.35
vs -0.30

Q3.23

-33%

-0.33
vs -0.35

Q4.23

-40%

-0.40
vs -0.33

Q1.24

-10%

-0.10
vs -0.40

Q2.24

-16%

-0.16
vs -0.10

Institutionnal Ownership

QoQ

Q3.22

15
vs 15

Q4.22

12
vs 15

-20%

Q1.23

14
vs 12

17%

Q2.23

11
vs 14

-21%

Q3.23

10
vs 11

-9%

Q4.23

11
vs 10

10%

Q1.24

12
vs 11

Q2.24

12
vs 12

Company Description

N/A

9.69x

0.59x

0.1

-1450.3%

$0.3

Earnings Growth

Latest News

New Feature Coming Soon, Stay Tuned!